how can drug resistance impact non-small cell lung cancer?
Published 1 year ago • 2.1K plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
3:32
understanding non-small cell lung cancer: types, biomarkers, and treatment insights
-
3:32
why non-small cell lung cancer patients should speak up about symptoms and side effects
-
1:49
how can drug resistance in lung cancer be reversed
-
2:54
what key tests impact lung cancer treatment choices?
-
3:42
how do lung cancer patients benefit from mrd testing?
-
5:50
hiding my battle with stage 4 lung cancer from my family (5% survival rate)
-
12:06
dying at home | sbs the feed
-
17:28
unit 3 - drug resistance in cancer
-
4:24
advice for managing lung cancer symptoms and treatment side effects
-
4:36
what do lung cancer patients need to know to build a treatment plan?
-
8:43
newly diagnosed non-small cell lung cancer | key advice for patients
-
3:31
small cell lung cancer care and outcomes in underrepresented communities
-
3:07
coping with small cell lung cancer rapid treatment
-
3:32
empowering lung cancer patients | embracing hope, treatment, and teamwork
-
2:33
confusion to clarity: expert explains the importance of nsclc mutations
-
6:04
key resources for small cell lung cancer patients and families
-
32:14
navigating the complexities of the nsclc treatment pathway: a focus on antibody-drug conjugates
-
4:04
improving biomarker testing access for rural lung cancer patients
-
3:56
key next steps after a lung cancer diagnosis: expert advice
-
2:58
expert advice for recently diagnosed lung cancer patients
-
2:43
how can we leverage lung cancer biomarker data to address health disparities?
-
2:54
pioneer: understanding pd-l1 resistances in non-small cell lung cancer